NEW YORK, March 31 (GenomeWeb News) - Dyadic International announced today that it will work with the Scripps Research Institute to provide a complete annotation of the genome of Chrysosporium lucknowense, Dyadic's proprietary fungal organism.
The organism, also known as C1, was sequenced last year by Agencourt Biosciences, a wholly owned subsidiary of Beckman Coulter.
The genome annotation work will be carried out at Scripps' new research center in
Financial details of the agreement were not disclosed.